Get the Stockscreener App
4.34
9.01%
-0.43
After Hours:
4.40
0.06
+1.38%
Lixte Biotechnology Holdings Inc stock is traded at $4.34, with a volume of 286.31K.
It is down -9.01% in the last 24 hours and down -27.73% over the past month.
Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.
See More
Previous Close:
$4.77
Open:
$4.77
24h Volume:
286.31K
Relative Volume:
1.54
Market Cap:
$19.80M
Revenue:
-
Net Income/Loss:
$-4.69M
P/E Ratio:
-1.8627
EPS:
-2.33
Net Cash Flow:
$-3.81M
1W Performance:
-14.06%
1M Performance:
-27.73%
6M Performance:
+258.68%
1Y Performance:
+133.33%
1-Day Range:
$4.28
$4.97
1-Week Range:
$4.28
$5.098
52-Week Range:
$0.64
$6.26
Lixte Biotechnology Holdings Inc Stock (LIXT) Company Profile
Name
Lixte Biotechnology Holdings Inc
Sector
Industry
Phone
310 203 2902
Address
248 ROUTE 25A, EAST SETAUKET
Compare LIXT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LIXT
Lixte Biotechnology Holdings Inc
|
4.34 | 21.76M | 0 | -4.69M | -3.81M | -2.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Lixte Biotechnology Holdings Inc Stock (LIXT) Latest News
Should you wait for a breakout in Lixte Biotechnology Holdings Inc. Equity WarrantJuly 2025 Selloffs & Verified Trade Idea Suggestions - newser.com
Should you wait for a breakout in Lixte Biotechnology Holdings Inc.Portfolio Performance Report & High Return Trade Opportunity Guides - newser.com
Evaluating Lixte Biotechnology Holdings Inc. with trendline analysisJuly 2025 Spike Watch & Daily Market Momentum Tracking - newser.com
How to recover losses in Lixte Biotechnology Holdings Inc. Equity Warrant stockJuly 2025 Analyst Calls & Expert Approved Momentum Ideas - newser.com
What institutional flow reveals about Lixte Biotechnology Holdings Inc.Price Action & AI Driven Stock Movement Reports - newser.com
How institutional ownership impacts Lixte Biotechnology Holdings Inc. Equity Warrant stockJuly 2025 News Drivers & AI Based Buy/Sell Signal Reports - newser.com
Is Lixte Biotechnology Holdings Inc. stock attractive after correctionAnalyst Downgrade & Pattern Based Trade Signal System - newser.com
Can swing trading help recover from Lixte Biotechnology Holdings Inc. lossesQuarterly Portfolio Report & Verified Momentum Stock Watchlist - newser.com
Can Lixte Biotechnology Holdings Inc. (8640) stock surprise markets with earningsMarket Activity Report & AI Forecast for Swing Trade Picks - newser.com
Why pension funds invest in Lixte Biotechnology Holdings Inc. (8640) stockWeekly Profit Report & Free Daily Entry Point Trade Alerts - newser.com
Will Lixte Biotechnology Holdings Inc. stock benefit from green energy trendsJuly 2025 PreEarnings & Reliable Breakout Stock Forecasts - newser.com
Published on: 2025-10-09 05:58:43 - newser.com
Top chart patterns to watch in Lixte Biotechnology Holdings Inc. Equity Warrant2025 Breakouts & Breakdowns & Safe Capital Allocation Plans - newser.com
Published on: 2025-10-09 04:56:37 - newser.com
Can Lixte Biotechnology Holdings Inc. Equity Warrant hit a new high this monthProfit Target & Fast Gain Swing Trade Alerts - newser.com
Why Lixte Biotechnology Holdings Inc. stock could benefit from AI revolution2025 Trade Ideas & Smart Swing Trading Techniques - newser.com
Using data tools to time your Lixte Biotechnology Holdings Inc. exitJuly 2025 News Drivers & Weekly High Return Stock Forecasts - newser.com
Can a trend reversal in Lixte Biotechnology Holdings Inc. lead to recovery2025 Breakouts & Breakdowns & High Accuracy Swing Trade Signals - newser.com
What dividend safety score for Lixte Biotechnology Holdings Inc. Equity Warrant stockJuly 2025 Action & Weekly High Potential Alerts - newser.com
Is Lixte Biotechnology Holdings Inc. (8640) stock included in top ETFsWeekly Trend Summary & Fast Moving Trade Plans - newser.com
Earnings visualization tools for Lixte Biotechnology Holdings Inc. Equity WarrantPortfolio Value Report & Risk Managed Trade Strategies - newser.com
Published on: 2025-10-05 04:39:19 - newser.com
Does Lixte Biotechnology Holdings Inc. fit your quant trading model2025 Support & Resistance & Fast Entry Momentum Alerts - newser.com
Is Lixte Biotechnology Holdings Inc. Equity Warrant forming a bottoming baseQuarterly Portfolio Report & Stepwise Trade Signal Implementation - newser.com
Published on: 2025-10-01 05:55:12 - newser.com
Lixte Biotechnology appoints new CFO and board members - MSN
What analysts say about Lixte Biotechnology Holdings Inc Equity Warrant stockBollinger Bands Signals & High Yield Stock Picks - earlytimes.in
Published on: 2025-09-30 05:43:55 - newser.com
Published on: 2025-09-29 14:33:14 - newser.com
Lixte Biotechnology Holdings Inc Stock (LIXT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):